Linked Life Data

19836982

Source:http://linkedlifedata.com/resource/pubmed/id/19836982

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19836982rdf:typepubmed:Citationlld:pubmed
pubmed-article:19836982lifeskim:mentionsumls-concept:C0027617lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0205474lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0019880lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0025646lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0443354lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0268583lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C1826260lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:19836982lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:19836982pubmed:issue2lld:pubmed
pubmed-article:19836982pubmed:dateCreated2010-2-3lld:pubmed
pubmed-article:19836982pubmed:abstractTextCombined methylmalonic aciduria and homocystinuria, cobalamin C (cblC) type, is an inherited disorder of vitamin B(12) metabolism caused by mutations in MMACHC. CblC typically presents in the neonatal period with neurological deterioration, failure to thrive, cytopenias, and multisystem pathology including renal and hepatic dysfunction. Rarely, affected individuals present in adulthood with gait ataxia and cognitive decline. Treatment with hydroxocobalamin may ameliorate the clinical features of early-onset disease and prevent clinical late-onset disease. Propionic acidemia (PA), methylmalonic acidemia (MMA), and various disorders of cobalamin metabolism are characterized by elevated propionylcarnitine (C3) on newborn screening (NBS). Distinctions can be made between these disorders with secondary analyte testing. Elevated methionine is already routinely used as a NBS marker for cystathionine beta-synthase deficiency. We propose that low methionine may be useful as a secondary analyte for specific detection of cbl disorders among a larger pool of infants with elevated C3 on NBS.lld:pubmed
pubmed-article:19836982pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:languageenglld:pubmed
pubmed-article:19836982pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:citationSubsetIMlld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19836982pubmed:statusMEDLINElld:pubmed
pubmed-article:19836982pubmed:monthFeblld:pubmed
pubmed-article:19836982pubmed:issn1096-7206lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:CagganaMichel...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:YuChunliClld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:WassersteinMe...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:DiazGeorge...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:Weisfeld-Adam...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:MorrisseyMark...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:KirmseBrian...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:SalvesonBobbi...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:McGuirePeter...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:SunnySherlyku...lld:pubmed
pubmed-article:19836982pubmed:authorpubmed-author:Cohen-Pfeffer...lld:pubmed
pubmed-article:19836982pubmed:copyrightInfoCopyright (c) 2009 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:19836982pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19836982pubmed:volume99lld:pubmed
pubmed-article:19836982pubmed:ownerNLMlld:pubmed
pubmed-article:19836982pubmed:authorsCompleteYlld:pubmed
pubmed-article:19836982pubmed:pagination116-23lld:pubmed
pubmed-article:19836982pubmed:dateRevised2011-4-12lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:meshHeadingpubmed-meshheading:19836982...lld:pubmed
pubmed-article:19836982pubmed:year2010lld:pubmed
pubmed-article:19836982pubmed:articleTitleNewborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.lld:pubmed
pubmed-article:19836982pubmed:affiliationProgram for Inherited Metabolic Diseases, Department of Genetics & Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA. james.weisfeld-adams@mssm.edulld:pubmed
pubmed-article:19836982pubmed:publicationTypeJournal Articlelld:pubmed